fda glp-1 compounding warning september 2025 and Novo Nordisk Warned of Telehealth Takedown. What's Next? FDA is short-sighted on compounding

One of the greatest advantages our facial plastic surgery team offers is the ability to forgo general anesthesia, which poses additional risks and concerns for many patients

Our focus is on helping you navigate these common concerns with clarity and confidence

The Study: Real-World Weight Loss Outcomes Researchers analyzed data from over 50,000 adults with obesity: 38,545 patients received a GLP-1 medication such as semaglutide or tirzepatide 12,540 patients underwent bariatric surgery, primarily gastric bypass or sleeve gastrectomy Key Findings : Surgery patients lost an average of 24% of their body weight over two years about 58 pounds

How Long Do Vitamin Injections Last in the Body

( Epub 20190909 )

Your healthcare provider will work with you to minimize the risk of these complications